Category : Clinical Research, Pharma & Healthcare Financing

GC Biopharma (006280.KS), a South Korean pharmaceutical company, announced that its varicella vaccine BARYCELA has received marketing authorization from the Drug Administration of Vietnam (DAV). Following domestic...

Ushur acknowledged in 4 different categories across the healthcare payer technology curve, earning its second consecutive recognition in this report. Ushur, the leader in AI-powered...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study...

Investment Will Accelerate PCI’s Leading Position in CDMO, Delivering Life-Changing Therapies to Patients Transaction Includes Continued Investment from Partners Group PCI Pharma Services (“PCI” or the...

Clinical study in Scientific Reports shows Bridge Capture™ detects key mutations from blood samples in metastatic colorectal cancer patients Genomill Health, a biotechnology company pioneering simplified targeted...

The Series B round saw strong participation from both existing and new investors, demonstrating high industry confidence in Illimis Therapeutics’ vision and technology. Eight existing investors,...

Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel gene-agnostic therapies for patients suffering severe vision loss from retinal degenerative diseases, today announced...

FN Media Group News Commentary – The global telehealth market has been substantially growing over the past years and is expected to continue this growth well into...

Pioneering a New Era in Healthcare: AI-Driven Innovation Unlocks Transformative Therapies and Drives Path to $50M Valuation Fifty1 AI Labs, LLC, a wholly owned subsidiary...

New indication based on results of RATIONALE-309 study demonstrating statistically significant improvement in progression-free survival Second approval for TEVIMBRA in the European Union this year...

Advancing corrector and potentiator programs to address underlying biology of autosomal dominant polycystic kidney disease (ADPKD) across multiple mutations Team includes preeminent scientific leaders in...

OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company advancing biomedical and wellness innovation, today announced the official roadmap for a targeted $50 million security token offering (STO)...

Fourth and final module of the PMA submitted in June Supportive analyses included in final module of the PMA meet both of the pre-specified co-primary...

Study Will Assess Real-World Effectiveness of Tri-Layer and Single-Layer Amnion Grafts in Treating Diabetic Foot and Venous Leg Ulcers BioLab Holdings, Inc., a Phoenix-based medical manufacturer...

Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities (Autorité des Marchés...